This Week in Healthcare Advertising: AI’s Impact on Pharma Marketing, The Rise of AVOD Viewing, and FDA Approvals

Staying up to date on every healthcare advertising trend is easier said than done these days, which is why we’re curating a weekly digest with all the top headlines on our radar. Check back every Friday for the latest news in healthcare advertising, pharma, and ad tech.

Healthcare Advertising Highlights

  • Artificial intelligence technology is impacting many industries. In this article for AdExchanger, Publicis Health Media’s GVP of data and technology Stefanos Kapetanakis talks about the role of AI in healthcare, and the opportunities it presents for pharma marketing and healthcare advertising.
  • According to Nielsen’s annual State of Play video report, ad-supported video-on-demand (AVOD) now accounts for 25% of total streaming time. AVODs are also attracting more diverse audiences than both traditional TV and subscription-based video-on-demand (SVOD); Pluto and Tubi each attract more than twice as many Black viewers as traditional linear TV.

Pharma Industry Updates

  • In COVID-related news, CureVac and GlaxoSmithKline starting the clinical development of a second-generation COVID-19 vaccine candidate, while a study from Merck and Ridgeback Biotherapeutics has shown that molnupiravir was associated with more rapid elimination of infections SARS-CoV-2 than placebo.
  • This week’s FDA approvals include Novartis’s alpelisib as the first drug to treat an ultra-rare cluster of conditions caused by mutations in a specific gene, and Gilead’s Yescarta as an initial treatment for adult patients with relapsed or refractory large B-cell lymphoma.
  • In partnerships and acquisitions, Pfizer is acquiring ReViral, a company focused on novel antiviral therapeutics for respiratory syncytial virus (RSV), and Takeda is partnering with Evozyne to develop next-generation therapies for up to four rare disease targets.

For more insights about healthcare advertising, sign up for our newsletter here.

More Insights

Innovating with intent a pharma-focused CTV forum
Blog Post
Innovating with Intent: Our Top 3 CTV Advertising Takeaways
In a first for DeepIntent, we hosted “Innovating with Intent: A Pharma-Focused CTV Forum,” an event focused exclusively on CTV advertising insights for pharma. Over...
Read More
Blue binoculars image with an orange bird icon and the word Birdwatching
Blog Post
Birdwatching: The Latest in Cookieless Advertising Tech
Welcome to Birdwatching, where we keep track of all the latest updates related to the avian-themed acronyms of the cookieless advertising world. DeepIntent is building...
Read More
white text on orange background that says all about ACR data
Blog Post
All About ACR Data: Your TV Campaign’s Missing Ingredient
Marketers today have access to more data than ever before — generated from so many sources — that can be used to power their advertising...
Read More
Back to Top